GSK 269962 - CAS 850664-21-0
Catalog number:
850664-21-0
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C29H30N8O5
Molecular Weight:
570.60
COA:
Inquire
Targets:
ROCK
Description:
GSK 269962 is a potent ROCK inhibitor with IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively, which displays greater than 30-fold selectivity for ROCK against a panel of serine/threonine kinases. It may be used in OAB treatment. It has been shown to block the generation of inflammatory cytokines in lipopolysaccharide-stimulated monocytes and to induce vasorelaxation in preconstricted rat aorta (IC50 = 35 nM). It lowers blood pressure in a rat model of hypertension. It induced a reduction in blood pressure of approximately 10, 20, and 50 mm Hg at doses of 1, 3, and 30 mg/kg. It represent a novel class of ROCK inhibitors that have profound effects in the vasculature, which may enable us to further evaluate the potential beneficial effects of ROCK inhibition in animal models of cardiovascular as well as other chronic diseases.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>99 %
Appearance:
Solid powder
Synonyms:
GSK269962A;N-[3-[[2-(4-Aminofurazan-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[[2-(4-morpholinyl)ethyl]oxy]benzamide;Aminofurazanyl-azabenzimidazole 6n;N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide
Solubility:
10 mM in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
GSK 269962 may be used in OAB treatment. It represent a novel class of ROCK inhibitors.
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Grams-Kilos
Density:
1.45±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
InChIKey:
YOVNFNXUCOWYSG-UHFFFAOYSA-N
InChI:
InChI=1S/C29H30N8O5/c1-2-37-24-17-25(31-18-23(24)33-28(37)26-27(30)35-42-34-26)41-22-5-3-4-20(16-22)32-29(38)19-6-8-21(9-7-19)40-15-12-36-10-13-39-14-11-36/h3-9,16-18H,2,10-15H2,1H3,(H2,30,35)(H,32,38)
Canonical SMILES:
CCN1C2=CC(=NC=C2N=C1C3=NON=C3N)OC4=CC=CC(=C4)NC(=O)C5=CC=C(C=C5)OCCN6CCOCC6
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related ROCK Products


GSK180736A
(CAS: 817194-38-0)

GSK180736A is a selective GRK2 inhibitor with an IC50 of 0.77 μM. It is also a weak inhibitor of PKA with an IC50 of 30 μM, but highly potent against ROCK1 (IC5...

CAS 1072959-67-1 N-[2-[2-(Dimethylamino)ethoxy]-4-(1H-pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxin-2-carboxamide

N-[2-[2-(Dimethylamino)ethoxy]-4-(1H-pyr
(CAS: 1072959-67-1)

SR 3677 is an effective ROCK inhibitor, espectially against ROCK II and it could block the phosphorylation ofmyosin light chain and promote the outflow of aqueo...

CAS 1342278-01-6 RKI-1447

RKI-1447
(CAS: 1342278-01-6)

Ripasudil (K-115)
(CAS: 887375-67-9)

Ripasudil (K-115) is potent ROCK inhibitor with IC50 of 51 nM and 19 nM for ROCK1 and ROCK2, respectively, used for the treatment of glaucoma and ocular hyperte...

CAS 105628-07-7 Fasudil hydrochloride

Fasudil hydrochloride
(CAS: 105628-07-7)

Fasudil HCl, a 5-isoquinolinesulfonamide derivative, is a highly selective Rho-associated protein kinase inhibitor that might have a rate in romoting the recove...

CAS 864082-47-3 GSK429286A

GSK429286A
(CAS: 864082-47-3)

GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM, respectively.

CAS 557782-81-7 ZINC00881524

ZINC00881524
(CAS: 557782-81-7)

ZINC00881524 is a specific ROCK inhibitor.

SAR-407899 hydrochloride
(CAS: 923262-96-8)

SAR-407899 hydrochloride is the hydrochloride form of SAR-407899, which is a potent, ATP-competitive ROCK inhibitor. It has good antihypertensive activity.

CAS 1273579-40-0 Chroman 1

Chroman 1
(CAS: 1273579-40-0)

Chroman 1, a chroman-based compound, is an effective ROCK II inhibitor which could probably influence the cell motility involved in sorts of disorders.

K-115
(CAS: 223645-67-8)

K-115, also called as Ripasudil or Glanatec, a selective ROCK inhibitor (IC50 =31 nM), is a promising emerging antiglaucoma drug, and was thus approved by the J...

CAS 129830-38-2 Y-27632 2HCl

Y-27632 2HCl
(CAS: 129830-38-2)

Y-27632 2HCl inhibits ROCK-II while displaying little activity against PKC, cAMP-dependent protein kinase and myosin light-chain kinase (MLCK) with Ki of 26 μM,...

CAS 867017-68-3 6-Chloro-n4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine

6-Chloro-n4-[3,5-difluoro-4-[(3-methyl-1
(CAS: 867017-68-3)

6-Chloro-n4-[3,5-difluoro-4-[(3-methyl-1H-pyrrolo[2,3-b]pyridin-4-yl)oxy]phenyl]-2,4-pyrimidinediamine is potent and highly selective ROCK inhibitor. Its IC50 v...

CAS 934387-35-6 ROCK-IN-1

ROCK-IN-1
(CAS: 934387-35-6)

A potent inhibitor of ROCK2 (IC50= 1.2 nM)

CAS 1226056-71-8 Thiazovivin

Thiazovivin
(CAS: 1226056-71-8)

CAS 146986-50-7 Y27632 2HCL

Y27632 2HCL
(CAS: 146986-50-7)

Verosudil
(CAS: 1414854-42-4)

Verosudil is a selective Rho-kinase inhibitor originated by Aerie Pharmaceuticals. In Jun 2013, Phase-II for Ocular hypertension in USA was discontinued. In Sep...

CAS 850664-21-0 GSK 269962

GSK 269962
(CAS: 850664-21-0)

GSK 269962 is a potent ROCK inhibitor with IC50 values are 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively, which displays greater than 30-fold ...

LX7101
(CAS: 1192189-69-7)

LX7101, a pyrrolopyrimidine derivative, is a LIM domain kinase 2 (LIMK2) inhibitor which could be probably effective in the treatment of glaucoma. It has just f...

SAR-407899
(CAS: 923359-38-0)

SAR-407899 is a potent, ATP-competitive ROCK inhibitor. It is equipotent against human and rat-derived Rho-kinase 2 with inhibition constant values of 36 nM and...

Netarsudil Mesylate
(CAS: 1422144-42-0)

Chemical Structure

CAS 850664-21-0 GSK 269962

Quick Inquiry

Verification code

Featured Items